Catalyst Capital Advisors’s Merck MRK Stock Holding History

Catalyst Capital Advisors’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-36,800	Closed	-$4.56M	–	550
2024 Q2	$4.56M	Sell	36,800 -200	-0.5%	-$25.8K	0.11%	75
2024 Q1	$4.88M	Sell	37,000 -700	-2%	-$86.3K	0.12%	68
2023 Q4	$4.11M	Sell	37,700 -3,000	-7%	-$311K	0.11%	74
2023 Q3	$4.19M	Sell	40,700 -1,550	-4%	-$167K	0.12%	74
2023 Q2	$4.88M	Sell	42,250 -2,300	-5%	-$261K	0.14%	64
2023 Q1	$4.74M	Sell	44,550 -3,050	-6%	-$329K	0.14%	61
2022 Q4	$5.28M	Buy	+47,600	New	+$4.87M	0.17%	55
2015 Q2	–	Sell	-8,384	Closed	-$460K	–	520
2015 Q1	$460K	Buy	+8,384	New	+$475K	0.05%	224

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Catalyst Capital Advisors's MRK Position: Q3 2024 in Review

Catalyst Capital Advisors sold out of Merck (MRK) in Q3 2024, closing a stake of 36,800 shares — an estimated $4.56M sold.

Catalyst Capital Advisors first reported a position in MRK in Q1 2015 and held it in 8 quarters. The position peaked at $5.28M in Q4 2022. 3,489 funds tracked by Wall St. Rank hold MRK as of Q3 2024.

Catalyst Capital Advisors reported no remaining Merck position as of Q3 2024 after selling out during the quarter.
Catalyst Capital Advisors sold 36,800 Merck shares in Q3 2024, an estimated $4.56M.
Catalyst Capital Advisors first reported a position in Merck in Q1 2015 and held it in 8 quarters.
Catalyst Capital Advisors's Merck position peaked at $5.28M in Q4 2022.
3,489 funds tracked by Wall St. Rank held Merck as of Q3 2024.

Based on Catalyst Capital Advisors's 13F filing for Q3 2024, filed 30 Oct 2024.